Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop
growing or die. Combining more than one drug may kill more tumor cells. It is not yet known
which chemotherapy regimen is more effective for stage III colon cancer. Randomized phase III
trial to compare the effectiveness of fluorouracil plus leucovorin with or without irinotecan
in treating patients who have undergone surgery for stage III colon cancer.
Phase:
Phase 3
Details
Lead Sponsor:
National Cancer Institute (NCI)
Collaborators:
Eastern Cooperative Oncology Group NCIC Clinical Trials Group North Central Cancer Treatment Group Southwest Oncology Group